HPTN Publications

Fogel JM, Piwowar-Manning E, Debevec B, Walsky T, Schlusser K, Laeyendecker O, Wilson EA, McCauley M, Gamble T, Tegha G, Soko D, Kumwenda J, Hosseinipour MC, Chen YQ, Cohen MS, Eshleman SH . Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays. J Acquir Immune Defic Syndr. 2017, 75: 426-430

Fogel JM, Piwowar-Manning E, Donohue K, Cummings V, Marzinke MA, Clarke W, Breaud A, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH . Determination of HIV Status in African Adults With Discordant HIV Rapid Tests. J Acquir Immune Defic Syndr. 2015, 69: 430-8

Fogel JM, Piwowar-Manning E, Moser A, Hill T, Ahmed S, Cummings V, Mostafa HH, Wang Z, Jennings A, Gallardo-Cartagena JA, Figueroa MI, St Clair M, Rinehart AR, Adeyeye A, Rooney JF, Cohen MS, Grinsztejn B, Landovitz RJ, Eshleman SH; HPTN 083 Study Team. . Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis. Microbiol Spectr. , 12

Fogel JM, Sandfort T, Zhang Y, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Eshleman SH . Accuracy of Self-Reported HIV Status Among African Men and Transgender Women Who Have Sex with Men Who were Screened for Participation in a Research Study: HPTN 075. AIDS Behav. 2019, 23: 289-294

Fogel JM, Sivay MV, Cummings V, Wilson EA, Hart S, Gamble T, Laeyendecker O, Fernandez RE, Del Rio C, Batey DS, Mayer KH, Farley JE, McKinstry L, Hughes JP, Remien RH, Beyrer C, Eshleman SH . HIV Drug Resistance in a Cohort of HIV-infected MSM in the United States [HPTN 078]. AIDS. 2020, 34: 91-101

Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, Mudhune VO, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, Panchia R, Kumarasamy N, Grinsztejn B, Makhema J, Pilotto J, Santos BR, Mayer KH, McCauley M, Gamble T, et. Al, Bumpus N, Hendrix C, Cohen M, Eshleman S . Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis. 2013, 208: 1624-8

Fogel JM, Wilson EA, Piwowar-Manning E, Breaud A, Clarke W, Petropoulos C, Moore A, Fraser C, Kosloff B, Shanaube K, van Zyl G, Scheepers M, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, Donnell D, Eshleman SH, HPTN 071 (PopART) Study Team . HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART).. J Int AIDS Soc. 2022, 25: e25941

Fogel JM, Zhang Y, Palumbo PJ, Guo X, Clarke W, Breaud A, Richardson P, Piwowar-Manning E, Hamilton EL, Ha TV, Dumchev K, Djoerban Z, Hoffman I, Hanscom B, Miller WC, Eshleman SH . Use of Antiretroviral Drug Testing to Assess the Accuracy of Self-reported Data from HIV-Infected People Who Inject Drugs. AIDS Behav.